GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Signatures Ltd (ASX:GSS) » Definitions » Days Payable

Genetic Signatures (ASX:GSS) Days Payable : 129.41 (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Genetic Signatures Days Payable?

Genetic Signatures's average Accounts Payable for the six months ended in Dec. 2024 was A$2.83 Mil. Genetic Signatures's Cost of Goods Sold for the six months ended in Dec. 2024 was A$3.98 Mil. Hence, Genetic Signatures's Days Payable for the six months ended in Dec. 2024 was 129.41.

The historical rank and industry rank for Genetic Signatures's Days Payable or its related term are showing as below:

ASX:GSS' s Days Payable Range Over the Past 10 Years
Min: 84.4   Med: 187.78   Max: 472.05
Current: 146.78

During the past 10 years, Genetic Signatures's highest Days Payable was 472.05. The lowest was 84.40. And the median was 187.78.

ASX:GSS's Days Payable is ranked better than
73.3% of 191 companies
in the Medical Diagnostics & Research industry
Industry Median: 59.34 vs ASX:GSS: 146.78

Genetic Signatures's Days Payable declined from Dec. 2023 (231.19) to Dec. 2024 (129.41). It may suggest that Genetic Signatures accelerated paying its suppliers.


Genetic Signatures Days Payable Historical Data

The historical data trend for Genetic Signatures's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Signatures Days Payable Chart

Genetic Signatures Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 99.37 84.40 93.95 164.04 228.54

Genetic Signatures Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 134.99 180.71 231.19 179.62 129.41

Competitive Comparison of Genetic Signatures's Days Payable

For the Diagnostics & Research subindustry, Genetic Signatures's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genetic Signatures's Days Payable Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetic Signatures's Days Payable distribution charts can be found below:

* The bar in red indicates where Genetic Signatures's Days Payable falls into.


;
;

Genetic Signatures Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Genetic Signatures's Days Payable for the fiscal year that ended in Jun. 2024 is calculated as

Days Payable (A: Jun. 2024 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Jun. 2023 ) + Accounts Payable (A: Jun. 2024 )) / count ) / Cost of Goods Sold (A: Jun. 2024 )*Days in Period
=( (3.77 + 3.065) / 2 ) / 5.458*365
=3.4175 / 5.458*365
=228.54

Genetic Signatures's Days Payable for the quarter that ended in Dec. 2024 is calculated as:

Days Payable (Q: Dec. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2024 ) + Accounts Payable (Q: Dec. 2024 )) / count ) / Cost of Goods Sold (Q: Dec. 2024 )*Days in Period
=( (3.065 + 2.585) / 2 ) / 3.984*365 / 2
=2.825 / 3.984*365 / 2
=129.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genetic Signatures Days Payable Related Terms

Thank you for viewing the detailed overview of Genetic Signatures's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Genetic Signatures Business Description

Traded in Other Exchanges
N/A
Address
7 Eliza Street, Newtown, Sydney, NSW, AUS, 2042
Genetic Signatures Ltd is a specialist molecular diagnostics company, specialising in syndromic multiplex real-time PCR testing. The company offers products for the routine detection of infectious diseases and pathogens. It has three operating segments based on regions: Asia Pacific, EMEA, and Americas. It generates the majority of its revenue from the Asia Pacific region. The group's operations are primarily based in Australia, with sales and support teams in the UK, Germany, and the United States.